LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 74.50 | 770.25 | 1542 | 10991 | 0.1403 | 0.1984 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 74.50 | 770.25 | 1750 | 10991 | 0.1592 | 0.2386 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 76.75 | 770.25 | 1557 | 11262 | 0.1382 | 0.1994 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 76.75 | 770.25 | 1718 | 11262 | 0.1525 | 0.2303 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 78.98 | 770.25 | 1537 | 11518 | 0.1334 | 0.1937 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 78.98 | 770.25 | 1776 | 11518 | 0.1542 | 0.2387 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 81.20 | 770.25 | 1559 | 11766 | 0.1325 | 0.1963 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 81.20 | 770.25 | 1864 | 11766 | 0.1584 | 0.2519 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 83.42 | 770.25 | 1564 | 12031 | 0.1300 | 0.1956 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 83.42 | 770.25 | 1759 | 12031 | 0.1462 | 0.2315 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 85.64 | 770.25 | 1565 | 12287 | 0.1274 | 0.1941 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 85.64 | 770.25 | 1802 | 12287 | 0.1467 | 0.2370 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 87.86 | 770.25 | 1558 | 12543 | 0.1242 | 0.1912 | MN20160304_L02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 87.86 | 770.25 | 1805 | 12543 | 0.1439 | 0.2356 | MN20160304_L02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 3.21 | 770.25 | 804 | 904 | 0.8888 | 0.2031 | MN20160304_L02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 3.21 | 770.25 | 827 | 904 | 0.9142 | 0.3586 | MN20160304_L02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 5.44 | 770.25 | 879 | 1012 | 0.8679 | 0.3972 | MN20160304_L02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 5.44 | 770.25 | 930 | 1012 | 0.9183 | 0.6117 | MN20160304_L02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 7.66 | 770.25 | 929 | 1090 | 0.8523 | 0.4537 | MN20160304_L02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 7.66 | 770.25 | 976 | 1090 | 0.8954 | 0.6042 | MN20160304_L02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 10.06 | 770.25 | 1004 | 1218 | 0.8240 | 0.4926 | MN20160304_L02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 10.06 | 770.25 | 1068 | 1218 | 0.8765 | 0.6387 | MN20160304_L02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 12.28 | 770.25 | 1097 | 1358 | 0.8077 | 0.5406 | MN20160304_L02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 12.28 | 770.25 | 1148 | 1358 | 0.8453 | 0.6286 | MN20160304_L02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 14.50 | 770.25 | 1183 | 1497 | 0.7901 | 0.5644 | MN20160304_L02 | I09 |